Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Federal Trade Commission
Merck
Julphar
Johnson and Johnson
Dow
Chubb
Cipla
Daiichi Sankyo
Farmers Insurance

Generated: January 23, 2018

DrugPatentWatch Database Preview

LEVOCETIRIZINE DIHYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Levocetirizine Dihydrochloride patents expire, and when can generic versions of Levocetirizine Dihydrochloride launch?

Levocetirizine Dihydrochloride is a drug marketed by Apotex Inc, L Perrigo Co, Silarx Pharms Inc, Taro Pharm Inds, Allied Pharma Inc, Dr Reddys Labs Ltd, Glenmark Generics, Hetero Labs Ltd Iii, Macleods Pharms Ltd, Sandoz, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Sun Pharma Global, Synthon Pharms, and Teva Pharms. and is included in seventeen NDAs.

The generic ingredient in LEVOCETIRIZINE DIHYDROCHLORIDE is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
Summary for LEVOCETIRIZINE DIHYDROCHLORIDE
Drug patent expirations by year for LEVOCETIRIZINE DIHYDROCHLORIDE
Pharmacology for LEVOCETIRIZINE DIHYDROCHLORIDE

US Patents and Regulatory Information for LEVOCETIRIZINE DIHYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride SOLUTION;ORAL 202915-001 Aug 21, 2014 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 203027-001 Feb 13, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro Pharm Inds LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride SOLUTION;ORAL 202673-001 Jul 26, 2013 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 090486-001 Mar 26, 2013 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 090392-001 Feb 24, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Synthon Pharms LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 090229-001 Nov 26, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 201653-001 Jun 26, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
L Perrigo Co LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride SOLUTION;ORAL 091263-001 Nov 7, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Silarx Pharms Inc LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride SOLUTION;ORAL 204599-001 May 15, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allied Pharma Inc LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 204323-001 Dec 20, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Colorcon
Harvard Business School
Novartis
Fuji
Chinese Patent Office
Farmers Insurance
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot